Literature DB >> 11641382

Invited review: sex ratio and rheumatic disease.

M D Lockshin1.   

Abstract

Human illnesses affect men and women differently. In some cases (diseases of sex organs, diseases resulting from X or Y chromosome mutations), reasons for sex discrepancy are obvious, but in other cases no reason is apparent. Explanations for sex discrepancy of illness occur at different biological levels: molecular (e.g., imprinting, X-inactivation), cellular (sex-specific receptor activity), organ (endocrine influences), whole organism (size, age), and environmental-behavioral, including intrauterine influences. Autoimmunity represents a prototypical class of illness that has high female-to-male (F/M) ratios. Although the F/M ratios in autoimmune diseases are usually attributed to the influence of estrogenic hormones, evidence demonstrates that the attributed ratios are imprecise and that definitions and classifications of autoimmune diseases vary, rendering at least part of the counting imprecise. In addition, many studies on sex discrepancy of human disease fail to distinguish between disease incidence and disease severity. In April 2001, the Institute of Medicine of the National Academy of Sciences published Exploring the Biological Contributions to Human Health: Does Sex Matter? (Wizemann T and Pardue M-L, editors). This minireview summarizes the section of that report that concerns autoimmune and infectious disease. Some thyroid, rheumatic, and hepatic autoimmune diseases have high F/M ratios, whereas others have low. Those that have high ratios occur primarily in young adulthood. Gonadal hormones, if they play a role, likely do so through a threshold or permissive mechanism. Examples of sex differences that could be caused by environmental exposure, X inactivation, imprinting, X or Y chromosome genetic modulators, and intrauterine influences are presented as alternate, theoretical, and largely unexplored explanations for sex differences of incidence. The epidemiology of autoimmune diseases (young, female) suggests that an explanation for sex discrepancy of these illnesses lies in differential exposure, vulnerable periods, or thresholds. Biologists have an opportunity to inform medical scientists about sex differences that explain different attack rates in specific diseases, and physicians offer biologists experiments of nature to test theories of sex.

Entities:  

Mesh:

Year:  2001        PMID: 11641382     DOI: 10.1152/jappl.2001.91.5.2366

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells.

Authors:  Carlos Penaloza; Brian Estevez; Shari Orlanski; Marianna Sikorska; Roy Walker; Catherine Smith; Brandon Smith; Richard A Lockshin; Zahra Zakeri
Journal:  FASEB J       Date:  2009-02-03       Impact factor: 5.191

Review 2.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

3.  Gender differences in stimulated cytokine production following acute psychological stress.

Authors:  Aric A Prather; Judith E Carroll; Jacqueline M Fury; Kevin K McDade; Diana Ross; Anna L Marsland
Journal:  Brain Behav Immun       Date:  2008-12-06       Impact factor: 7.217

Review 4.  Sex-specific environmental influences on the development of autoimmune diseases.

Authors:  Eleni Tiniakou; Karen H Costenbader; Martin A Kriegel
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

5.  Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA.

Authors:  Carlos G Penaloza; Brian Estevez; Dinah M Han; Melissa Norouzi; Richard A Lockshin; Zahra Zakeri
Journal:  FASEB J       Date:  2013-10-25       Impact factor: 5.191

6.  Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line.

Authors:  Maurizio Cutolo; Silvia Capellino; Paola Montagna; Paola Ghiorzo; Alberto Sulli; Barbara Villaggio
Journal:  Arthritis Res Ther       Date:  2005-07-21       Impact factor: 5.156

7.  Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan.

Authors:  Ken Nakajima; Omi Watanabe; Mayumi Mochizuki; Ayako Nakasone; Nobuhiko Ishizuka; Atsuko Murashima
Journal:  Mod Rheumatol       Date:  2016-03-04       Impact factor: 3.023

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.